![Rachel H. Rondinelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Rachel H. Rondinelli
Anciens postes connus de Rachel H. Rondinelli
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cenix BioScience GmbH
![]() Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Corporate Officer/Principal | - | - |
Formation de Rachel H. Rondinelli
Millersville University | Undergraduate Degree |
Michigan State University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Cenix BioScience GmbH
![]() Cenix BioScience GmbH Miscellaneous Commercial ServicesCommercial Services Cenix BioScience is a contract research organization specialized in combining advanced applications of RNAi with high content phenotypic analyses to enhance and accelerate the discovery and pre-clinical development of novel therapeutics. Cenix has built up a solid track record, successfully advancing therapeutic programs for numerous major industry and academic partners by addressing the specific needs of each through fully-customized, cutting-edge research offerings covering a wide range of disease fields. The well-established core capabilities in high throughput RNAi and multi-parametric microscopy assays have yielded optimized protocols in a broad and ever-growing collection of cultured cell models, and are now complemented by microRNA-focused experimentation and in vivo applications of synthetic siRNAs. As such, Cenix is a mature and fully-proven industrial research provider, applying the highest of scientific best practices and offering a breadth and depth of expertise second to none world wide | Commercial Services |
- Bourse
- Insiders
- Rachel H. Rondinelli
- Expérience